539680 — GANGA PHARMACEUTICALS Balance Sheet
0.000.00%
- IN₹73.89m
- IN₹84.21m
- IN₹28.28m
Annual balance sheet for GANGA PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.29 | 0.298 | 3.02 | 0.582 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 23.3 | 24.3 | 34.5 | 38.6 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 51.5 | 57.5 | 68.7 | 75.6 |
| Net Property, Plant And Equipment | 6.39 | 6.12 | 6.65 | 6.46 |
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 79.8 | 86.5 | 89.7 | 96.5 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 18.9 | 12 | 16 | 12.4 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 25.3 | 16 | 18.4 | 13.4 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 54.5 | 70.5 | 71.3 | 83.1 |
| Total Liabilities & Shareholders' Equity | 79.8 | 86.5 | 89.7 | 96.5 |
| Total Common Shares Outstanding |